Bendazac
| |
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration | Topical |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
KEGG |
|
ChEBI | |
ChEMBL | |
ECHA InfoCard |
100.039.594 |
Chemical and physical data | |
Formula | C16H14N2O3 |
Molar mass | 282.294 g/mol |
3D model (JSmol) | |
| |
| |
|
Bendazac (or bendazolic acid) is a nonsteroidal anti-inflammatory drug (NSAID) used for joint and muscular pain.
Synthesis
Principal action is inhibition of protein denaturation.
Use of chloroacetamide in the alkylation step, followed by acid hydrolysis produces bendazac (instead of benzydamine).
See also
References
Pyrazolones / Pyrazolidines | |
---|---|
Salicylates | |
Acetic acid derivatives and related substances | |
Oxicams | |
Propionic acid derivatives (profens) |
|
N-Arylanthranilic acids (fenamates) | |
Coxibs | |
Other | |
Items listed in bold indicate initially developed compounds of specific groups. #WHO-EM †Withdrawn drugs. ‡Veterinary use medications. |
Anti-inflammatory preparations, non-steroids |
| ||||||
---|---|---|---|---|---|---|---|
Capsaicin derivatives | |||||||
Other |
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.